Less than 20% of IRBs Utilize Central IRB Despite Revised GCP Ordinance: Dr Narumoto of Okayama Univ.

Dr Yuka Narumoto of the Division of Clinical Research of New Drugs and Therapeutics, Center for Innovative Clinical Medicine, Okayama University Hospital, reported the results of a recent survey on institutional review boards (IRBs) in Japan at the 33rd annual...read more